Adult ECAT protocol

Shortness of breath

A2.1 Published: December 2023. Printed on 21 Nov 2024.

QR code link to ECI website

Get the latest version


Any person, 16 years and over, presenting with shortness of breath or flu-like illness.

This protocol is intended to be used by registered and enrolled nurses within their scope of practice and as outlined in The Use of Emergency Care Assessment and Treatment Protocols (PD2024_011). Sections marked triangle or diamond indicate the need for additional prerequisite education prior to use. Check the medication table for dose adjustments and links to relevant reference texts.

History prompts, signs and symptoms

These are not exhaustive lists. Maintain an open mind and be aware of cognitive bias.

History prompts

  • Presenting complaint
  • Onset of symptoms
  • Triggers, including breathlessness on exertion
  • Recent illness
  • Pain assessment – PQRST
  • Pre-hospital treatment
  • Past admissions
  • Medical and surgical history, including immobility, pulmonary embolism, DVT or ICU intubations
  • Current medications
  • Known allergies
  • Recent travel, including at altitudes or diving (SCUBA)
  • Recent contact with sick persons
  • Smoking history

Signs and symptoms

  • Respiratory distress
  • Tachypnoeic
  • Cough or haemoptysis
  • Sore throat
  • Runny nose
  • Hypoxia
  • Abnormal breath sounds
  • Palpitations
  • Fatigue
  • Anxiety
  • Fever

Red flags

Recognise: identify indicators of actual or potential clinical severity and risk of deterioration.

Respond: carefully consider alternative ECAT protocol. Escalate as per clinical reasoning and local CERS protocol, and continue treatment.

Historical

  • Known or suspected foreign body aspiration
  • Malignancy
  • Pregnant or postpartum (3/12)
  • Previous history of intubation or ICU admission
  • Recent long-haul travel
  • Unresponsive to pre-hospital management
  • Anaphylaxis

Clinical

  • Altered level of consciousness
  • Tripod positioning
  • Oropharyngeal swelling
  • Stridor
  • Severe respiratory distress
  • Talking in words only
  • Bradypnoea
  • Silent chest
  • Cyanosis
  • Chest pain
  • Pre-syncope
  • Cardiac arrythmia
  • Fever
  • Urticarial rash

Remember adult at risk: patient or carer concern, frailty, multiple comorbidities or unplanned return.

Clinical assessment and specified intervention (A to G)

If the patient has any Yellow or Red Zone observations or additional criteria (as per the relevant NSW Standard Emergency Observation Chart), refer and escalate as per local CERS protocol and continue treatment.

Position

AssessmentIntervention

General appearance/first impressions

Position of comfort

Preferably semi-reclined or upright

Airway

AssessmentIntervention

Patency of airway

Maintain airway patency

Consider airway opening manoeuvres and positioning

Breathing

AssessmentIntervention

Respiratory rate and effort

Auscultate chest (breath sounds)

Oxygen saturation (SpO2)

Assist ventilation, as clinically indicated

Consider oxygen if dyspnoeic, titrate oxygen to maintain SpO2 over 93%

Circulation

AssessmentIntervention

Perfusion (capillary refill, skin warmth and colour)

Pulse

Blood pressure

Cardiac rhythm

Assess circulation

Attach cardiac monitor and complete 12 lead ECG if BP/HR are within the Yellow or Red Zones, or where clinically relevant, e.g. irregular pulse, palpitations, syncope, shock, respiratory compromise, cardiac history or clinical concern

If audible respiratory crepitation and raised JVP and/or peripheral oedema, switch to shortness of breath with a history of cardiac disease protocol

IVC and/or pathology

Insert IV cannula, if trained

If unable to obtain IV access, consider intraosseous, if trained

See pathology section

Signs of shock:

tachycardia and CRT 3 seconds and over

and/or abnormal skin perfusion

and/or hypotension

If signs of shock present and/or SBP less than 90 mmHg, give 250 mL of sodium chloride 0.9% IV/intraosseous bolus

Repeat every 10 minutes (up to 1000 mL) until SBP over 90 mmHg or signs of shock have resolved

If patient meets sepsis criteria, switch to sepsis (suspected) protocol

Disability

AssessmentIntervention
ACVPU

If ACVPU shows reduced level of consciousness, continue to GCS, pupillary response and limb strength

GCS, pupillary response and limb strength

Obtain baseline and repeat assessment, as clinically indicated

Pain
Assess pain. If indicated, give early analgesia as per analgesia section then resume A to G assessment

Exposure

AssessmentIntervention
Temperature

Measure temperature

Skin inspection, including posterior surfaces

Check and document any abnormalities

Fluids

AssessmentIntervention
Hydration status: last ate, drank, bowels opened, passed urine or vomited Commence fluid balance chart, as required
Nausea and/or vomiting If present, see nausea and/or vomiting section
NBM

Consider clear fluids or NBM based on red flags and clinical severity

Glucose

AssessmentIntervention

BGL

Measure BGL, if clinically indicated

If less than 4 mmol/L, consider hypoglycaemia protocol

Repeat and document assessment and observations to monitor responses to interventions, identify developing trends and clinical deterioration. Escalate care as required according to the local CERS protocol.

Focused assessment

Complete cardiovascular focused assessment.

Complete respiratory focused assessment.

Precautions and notes

  • Common life-threatening causes of SOB that should be considered include, but are not limited to:
    • ACS
    • pulmonary oedema
    • arrhythmia
    • pulmonary embolism
    • anaphylaxis
    • pneumonia
    • COPD
    • sepsis
    • angioedema
    • pneumothorax
    • haemothorax
    • acute renal failure
    • anaemia
    • epiglottitis
  • Consider using alternate protocol once further history and assessment are obtained.
  • Isolate patients and use appropriate PPE when attending potentially infective patients.

Interventions and diagnostics

Specific treatment

If wheeze is present or quiet breath sounds, consider shortness of breath with a history of asthma protocol.

If ineffective respiratory effort, consider non-invasive ventilation where available and escalate as per local CERS protocol if required.


Analgesia

Select pain score:

Pain score 1–3 (mild)

Give paracetamol 1000 mg orally once only

and/or ibuprofen 400 mg orally once only

Pain score 4–6 (moderate)

Give:

oxycodone (immediate release):

  • 16–65 years: 5 mg orally and, if required, repeat once after 30 minutes, maximum dose 10 mg
  • 65 years and over: 2.5 mg orally and, if required, repeat once after 30 minutes, maximum dose 5 mg

and/or paracetamol 1000 mg orally once only

and/or ibuprofen 400 mg orally once only

Pain score 7–10 (severe)

Give one of:

Fentanyl intranasal
  • 16–65 years: 50 microg intranasally and, if required, repeat once after 5 minutes, maximum dose 100 microg. Dose to be divided between nostrils
  • 65 years and over: 25 microg intranasally and, if required, repeat once after 5 minutes, maximum dose 50 microg. Dose to be divided between nostrils

Note: ensure an extra 0.1 mL is drawn up for the first dose to account for the dead space in the mucosal atomiser device

Fentanyl IV
  • 16–65 years: 50 microg IV and, if required, repeat once after 5 minutes, maximum dose 100 microg
  • 65 years and over: 25 microg IV and, if required, repeat once after 5 minutes, maximum dose 50 microg
Morphine IV
  • 16–65 years: 5 mg IV and, if required, repeat once after 5 minutes, maximum dose 10 mg
  • 65 years and over: 2.5 mg IV and, if required, repeat once after 5 minutes, maximum dose 5 mg
Morphine IM
  • 16–65 years: 5 mg IM and, if required, repeat once after 60 minutes, maximum dose 10 mg
  • 65 years and over: 2.5 mg IM and, if required, repeat once after 60 minutes, maximum dose 5 mg

and/or paracetamol 1000 mg orally once only

and/or ibuprofen 400 mg orally once only

If pain does not improve with medication, escalate as per local CERS protocol.


Nausea and/or vomiting

If nausea and/or vomiting is present, give:

  • metoclopramide 10 mg orally or IV/IM once only (over 20 years only)
  • or ondansetron 4 mg orally or IV/IM. If symptoms persist after 60 minutes, repeat once, maximum dose 8 mg
  • or prochlorperazine 5 mg orally once only or 12.5 mg IV/IM once only

Choice of antiemetic should be determined by cause of symptoms.


Radiology

  • If life-threatening or concern for pneumothorax: CXR

Pathology

  • FBC, UEC
  • Moderate to severe respiratory distress: ABG (if trained) or VBG
  • Suspected cardiac cause: troponin
  • Warfarinised: INR
  • Temp less than 35°C, or 38.5°C and above: take two sets of blood cultures from two separate sites
  • If clinically indicated: respiratory viral PCR screen, sputum culture, urinary antigens for pneumococcus and legionella

Medications

The shaded sections in this protocol are only to be used by registered nurses who have completed the required education.

Drag the table right to view more columns or turn your phone to landscape

Drug Dose Route Frequency

16–65 years
50 microg
Maximum dose 100 microg

65 years and over:
25 microg
Maximum dose 50 microg

IV/intranasal

Pain score 7–10

Repeat once if required after 5 minutes to maximum dose

Ibuprofen H, R

400 mg

Oral

Pain score 1–10

Once only

Metoclopramide R

Over 20 years:
10 mg

Oral/IV/IM

Once only

16–65 years
5 mg
Maximum dose 10 mg

65 years and over:
2.5 mg
Maximum dose 5 mg

Pain score 7–10

IV Repeat once if required after 5 minutes
IM Repeat once if required after 60 minutes

Ondansetron

4 mg

Maximum dose 8 mg

Oral/IV/IM

Repeat once if required after 60 minutes

16–65 years:
5 mg
Maximum dose 10 mg

65 years and over:
2.5 mg
Maximum dose 5 mg

Oral

Pain score 4–6

Repeat once if required after 30 minutes to maximum dose

Oxygen

2–15 L/min, device dependent

Inhalation

Continuous

Paracetamol H

1000 mg

Oral

Pain score 1–10

Once only

5 mg

Oral

Once only

OR

12.5 mg

IV/IM

Once only

Sodium chloride 0.9%

250 mL

Maximum dose 1000 mL

IV/intraosseous

Bolus

Repeat every 10 minutes (up to 1000 mL) until SBP over 90 mmHg or signs of shock have resolved

Medications with contraindications or requiring dose adjustment are marked:

  • H for patients with known hepatic impairment
  • R for patients with known renal impairment.

Escalate to medical or nurse practitioner.

References

Hide references

Evidence informed

Information was drawn from evidence-based guidelines and a review of latest available research. For more information, see the development process.

Collaboration

This protocol was developed by the ECAT Working Group, led by the Agency for Clinical Innovation. The group involved expert medical, nursing and allied health representatives from local health districts across NSW. Consensus was reached on all recommendations included within this protocol.

Currency Due for review: Jan 2026. Based on a regular review cycle.
Feedback Email ACI-ECIs@health.nsw.gov.au

Accessed from the Emergency Care Institute website at https://aci.health.nsw.gov.au/ecat/adult/shortness-of-breath

Back to top